blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2968296

EP2968296 - GAMMA-SECRETASE MODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.07.2021
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  31.07.2020
FormerGrant of patent is intended
Status updated on  26.03.2020
FormerExamination is in progress
Status updated on  25.05.2018
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 5th Floor
Oakland, CA 94607-5200 / US
For all designated states
Tanzi, Rudolph E.
114 16th Street
Charlestown, Massachusetts 02129 / US
[2016/03]
Inventor(s)01 / TANZI, Rudolph E.
114 16th Street
Charlestown, Massachusetts 02129 / US
02 / WAGNER, Steven L.
2315 Wilbur Avenue
San Diego, California 92109 / US
03 / CHENG, Soan
5045 Seachase Street
San Diego, California 92130 / US
04 / MOBLEY, William C.
8263 Camino Del Oro
273
La Jolla, California 92037 / US
 [2016/03]
Representative(s)Forresters IP LLP
Skygarden
Erika-Mann-Straße 11
80636 München / DE
[N/P]
Former [2020/36]Bond, Christopher William
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Former [2016/03]Donald, Jenny Susan
Forresters
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Application number, filing date14779909.212.03.2014
[2016/03]
WO2014US25016
Priority number, dateUS201361777941P12.03.2013         Original published format: US 201361777941 P
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014165263
Date:09.10.2014
Language:EN
[2014/41]
Type: A1 Application with search report 
No.:EP2968296
Date:20.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2014 takes the place of the publication of the European patent application.
[2016/03]
Type: B1 Patent specification 
No.:EP2968296
Date:02.09.2020
Language:EN
[2020/36]
Search report(s)International search report - published on:US09.10.2014
(Supplementary) European search report - dispatched on:EP07.09.2016
ClassificationIPC:C07D417/14, C07D487/04, A61K31/4436, A61P25/28
[2020/16]
CPC:
C07D417/14 (EP,US); C07D487/04 (EP,US)
Former IPC [2016/03]A61K31/4436
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/03]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:GAMMASEKRETASEMODULATOREN[2016/03]
English:GAMMA-SECRETASE MODULATORS[2016/03]
French:MODULATEURS DE GAMMA-SECRÉTASE[2016/03]
Entry into regional phase08.10.2015National basic fee paid 
08.10.2015Search fee paid 
08.10.2015Designation fee(s) paid 
08.10.2015Examination fee paid 
Examination procedure08.10.2015Examination requested  [2016/03]
28.03.2017Amendment by applicant (claims and/or description)
29.05.2018Despatch of a communication from the examining division (Time limit: M06)
29.11.2018Reply to a communication from the examining division
18.03.2019Despatch of a communication from the examining division (Time limit: M04)
21.03.2019Reply to a communication from the examining division
06.09.2019Despatch of a communication from the examining division (Time limit: M04)
12.12.2019Reply to a communication from the examining division
27.03.2020Communication of intention to grant the patent
24.07.2020Fee for grant paid
24.07.2020Fee for publishing/printing paid
24.07.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.05.2018
Opposition(s)03.06.2021No opposition filed within time limit [2021/32]
Fees paidRenewal fee
31.03.2016Renewal fee patent year 03
27.03.2017Renewal fee patent year 04
27.03.2018Renewal fee patent year 05
27.03.2019Renewal fee patent year 06
27.03.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.03.2014
AL02.09.2020
AT02.09.2020
CY02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
MK02.09.2020
MT02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
IE12.03.2021
LU12.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
[2024/41]
Former [2024/22]HU12.03.2014
AL02.09.2020
AT02.09.2020
CY02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
MK02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
IE12.03.2021
LU12.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2023/30]HU12.03.2014
AL02.09.2020
AT02.09.2020
CY02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
IE12.03.2021
LU12.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2023/27]HU12.03.2014
AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
IE12.03.2021
LU12.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/34]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
IE12.03.2021
LU12.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/11]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
IE12.03.2021
LU12.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/09]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
IE12.03.2021
LU12.03.2021
Former [2022/07]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
IE12.03.2021
Former [2021/48]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
IT02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/45]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/37]AL02.09.2020
AT02.09.2020
CZ02.09.2020
DK02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/36]AL02.09.2020
AT02.09.2020
CZ02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/28]AL02.09.2020
AT02.09.2020
CZ02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/25]AL02.09.2020
AT02.09.2020
CZ02.09.2020
EE02.09.2020
ES02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/24]AT02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/23]CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
SM02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/22]CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/21]FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RS02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/18]FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
NL02.09.2020
PL02.09.2020
RS02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
Former [2021/10]FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RS02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
Former [2021/09]FI02.09.2020
LT02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
GR03.12.2020
Former [2021/08]FI02.09.2020
LT02.09.2020
SE02.09.2020
BG02.12.2020
NO02.12.2020
Former [2021/07]FI02.09.2020
LT02.09.2020
NO02.12.2020
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[A]WO2004018997  (NEUROGENETICS INC [US], et al);
 [A]US2011118236  (MOCHIZUKI MICHIYO [JP], et al);
 [A]WO2011163636  (UNIV CALIFORNIA [US], et al);
 [A]US2013023534  (CASILLAS LINDA N [US], et al)
by applicantUS4861760
 US4911920
 US5212162
 US5403841
 US7244939
 WO2011163636
    - CORIC, V. et al., Arch Neurol., (20120000), vol. 69, pages 1430 - 1440
    - WAKABAYASHI T.; DE STROOPER, B., Physiology, (20080000), vol. 23, pages 194 - 204
    - FLEISHER A.S. et al., Arch Neurol., (20080000), vol. 65, pages 1031 - 1038
    - KOPAN, R.; ILAGAN, M.X., Nat. Rev. Mol. Cell. Biol., (20040000), vol. 5, pages 486 - 488
    - KUKAR, T.L. et al., Nature, (20080000), vol. 453, pages 925 - 929
    - GREEN, R.C. et al., J. Amer. Med. Asso., (20090000), vol. 302, pages 2557 - 2564
    - KOUNNAS, M.Z. et al., Neuron, (20100000), vol. 67, pages 769 - 780
    - BERGE et al., "Pharmaceutical Salts", Journal of Pharmaceutical Science, (19770000), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560

DOI:   http://dx.doi.org/10.1002/jps.2600660104
    - LIEBERMAN, Pharmaceutical Dosage Forms, (19920000), vol. 1-3
    - RAO, J. Biomater Sci. Polym. Ed., (19950000), vol. 7, pages 623 - 645
    - GAO, Pharm. Res., (19950000), vol. 12, pages 857 - 863
    - EYLES, J. Pharm. Pharmacol., (19970000), vol. 49, pages 669 - 674
    - AL-MUHAMMED, J. Microencapsul., (19960000), vol. 13, pages 293 - 306
    - CHONN, Curr. Opin. Biotechnol., (19950000), vol. 6, pages 698 - 708
    - OSTRO, Am. J. Hosp. Pharm., (19890000), vol. 46, pages 1576 - 1587
    - FINGL et al., THE PHARMACOLOGICAL BASIS OF THERAPEUTICS, (19750000), page l
    - NETZER, WI et al., Gleevec inhibits β-amyloid production but not Notch cleavage
    - Proc. Natl. Acad. Sci. U.S.A., (20030000), vol. 100, pages 12444 - 12449
    - LANZ TA et al., J Pharmacol Exp Ther, (20060000), vol. 319, pages 924 - 933
    - ABRAMOSWKI D et al., J Pharmacol Exp Ther., (20080000), vol. 327, pages 411 - 424
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.